BIONPHARMA, INC.
Pharmaceutical ManufacturingNew York, United States11-50 Employees
BIONPHARMA, INC. is a pharmaceuticals company based out of 1751 STATE ROUTE 17A, FLORIDA, New York, United States.
Growth Potential BIONPHARMA's revenue range of $25 million to $50 million and recent $6.5 million funding indicate a company in expansion mode, offering opportunities for partners to support their scaling efforts.
Supply Chain Focus The company's recent voluntary recall of Atovaquone Oral Suspension highlights a focus on quality control and regulatory compliance, suggesting potential needs for supply chain and manufacturing optimization solutions.
Partnership Opportunities BIONPHARMA's strategic investments in and collaborations with CoreRx demonstrate openness to partnership and infrastructure enhancement, presenting avenues for technology or service providers to deepen their engagement.
Product Innovation Launching FDA-approved products like Clobazam Suspension shows BIONPHARMA's commitment to pharmaceutical innovation, creating opportunities for companies offering pharmaceutical R&D, formulation, or regulatory support services.
Industry Positioning As a midsized pharmaceutical manufacturer competing with larger firms such as Dr. Reddy's and Amneal, BIONPHARMA may be receptive to solutions that bolster operational efficiency or competitive advantage in a dynamic market.
BIONPHARMA, INC. uses 8 technology products and services including oEmbed, WooCommerce, Microsoft 365, and more. Explore BIONPHARMA, INC.'s tech stack below.
| BIONPHARMA, INC. Email Formats | Percentage |
| First@bionpharma.com | 54% |
| FLast@bionpharma.com | 25% |
| Last@bionpharma.com | 13% |
| FirstL@bionpharma.com | 8% |
Pharmaceutical ManufacturingNew York, United States11-50 Employees
BIONPHARMA, INC. is a pharmaceuticals company based out of 1751 STATE ROUTE 17A, FLORIDA, New York, United States.
BIONPHARMA, INC. has raised a total of $6.5M of funding over 3 rounds. Their latest funding round was raised on Dec 14, 2015 in the amount of $6.5M.
BIONPHARMA, INC.'s revenue is estimated to be in the range of $25M$50M
BIONPHARMA, INC. has raised a total of $6.5M of funding over 3 rounds. Their latest funding round was raised on Dec 14, 2015 in the amount of $6.5M.
BIONPHARMA, INC.'s revenue is estimated to be in the range of $25M$50M